239 related articles for article (PubMed ID: 12577966)
21. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946
[TBL] [Abstract][Full Text] [Related]
22. Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Jan; 65(4):1000-50. PubMed ID: 11010621
[TBL] [Abstract][Full Text] [Related]
23. Ophthalmic drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
Food and Drug Administration, HHS
Fed Regist; 2003 Feb; 68(33):7919-21. PubMed ID: 12593411
[TBL] [Abstract][Full Text] [Related]
24. Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Feb; 67(27):5942-3. PubMed ID: 11837282
[TBL] [Abstract][Full Text] [Related]
25. Iron-containing supplements and drugs; label warning statements and unit-dose packaging requirements; removal of regulations for unit-dose packaging requirements for dietary supplements and drugs. Final rule; removal of regulatory provisions in response to court order.
Food and Drug Administration, HHS
Fed Regist; 2003 Oct; 68(201):59714-5. PubMed ID: 14567392
[TBL] [Abstract][Full Text] [Related]
26. Antidiarrheal drug products for over-the-counter human use; amendment of final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 May; 69(92):26301-2. PubMed ID: 15141675
[TBL] [Abstract][Full Text] [Related]
27. Labeling of diphenhydramine-containing drug products for over-the-counter human use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Dec; 67(235):72555-9. PubMed ID: 12474879
[TBL] [Abstract][Full Text] [Related]
28. Bar code label requirement for human drug products and biological products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Feb; 69(38):9119-71. PubMed ID: 14986679
[TBL] [Abstract][Full Text] [Related]
29. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for over-the-counter nasal decongestant drug products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2005 Oct; 70(195):58974-7. PubMed ID: 16217879
[TBL] [Abstract][Full Text] [Related]
30. Amendment to examination and investigation sample requirements--FDA. Direct final rule.
Fed Regist; 1998 Sep; 63(186):51297-9. PubMed ID: 10185810
[TBL] [Abstract][Full Text] [Related]
31. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of monograph for OTC nasal decongestant drug products. Final rule.
Fed Regist; 2006 Aug; 71(147):83358[sic., should be 43358]-63. PubMed ID: 16892519
[TBL] [Abstract][Full Text] [Related]
32. Skin protectant drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
Food and Drug Administration, HHS
Fed Regist; 2003 Dec; 68(236):68509-11. PubMed ID: 14664244
[TBL] [Abstract][Full Text] [Related]
33. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 May; 67(90):31123-5. PubMed ID: 12001971
[TBL] [Abstract][Full Text] [Related]
34. Revision to requirements for licensed Anti-Human Globulin and Blood Grouping Reagents. Food and Drug Administration, HHS. Direct final rule.
Fed Regist; 2000 Dec; 65(239):77497-9. PubMed ID: 11503726
[TBL] [Abstract][Full Text] [Related]
35. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients--FDA. Final rule.
Fed Regist; 1998 Dec; 63(231):66631-72. PubMed ID: 10338880
[TBL] [Abstract][Full Text] [Related]
36. Drug labeling; orally ingested over-the-counter drug products containing calcium, magnesium, and potassium. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Mar; 69(57):13725-35. PubMed ID: 15040351
[TBL] [Abstract][Full Text] [Related]
37. Labeling for bronchodilators to treat asthma; cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2011 Jul; 76(143):44475-89. PubMed ID: 21796845
[TBL] [Abstract][Full Text] [Related]
38. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; partial final rule for combination drug products containing a bronchodilator. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2001 Sep; 66(188):49276-8. PubMed ID: 11758596
[TBL] [Abstract][Full Text] [Related]
39. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(110):34273-93. PubMed ID: 12795305
[TBL] [Abstract][Full Text] [Related]
40. Food labeling: health claims; omega-3 fatty acids and the risk in adults of cardiovascular disease--FDA. Interim final rule.
Fed Regist; 1998 Jun; 63(119):34107-10. PubMed ID: 10180289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
